ENTITY

Sichuan Kelun-Biotech Biopharm (6990 HK)

30
Analysis
Health CareChina
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. operates biotechnology businesses. The Company develops and provides biological drugs, chemical raw materials, antibody conjugating drugs, innovative drugs, and other products. Kelun Biotech also operates import and export businesses.
more
11 Aug 2024 10:05

Hong Kong Connect Flows (Aug 9th): Tencent, Xiaomi Corporation, CCB, CNOOC, HSBC

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Tencent, Xiaomi Corporation, CCB, CNOOC, HSBC.

Logo
315 Views
Share
04 Aug 2024 10:05

Hong Kong Connect Flows (Aug 2nd): Tencent, China Petroleum & Chemical Corporation, Power Assets

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Tencent, China Petroleum & Chemical Corporation, BOC,...

Logo
974 Views
Share
bearishRemegen
14 Jul 2024 09:26

China Healthcare Weekly (July.14) - CXO's Disputed Business Model, Remegen Shares Plunged, Kelun Bio

​China CXOs prioritize investment over R&D, leading to potential conflicts of interest. Investors challenged RemeGen due to poor outlook. After...

Logo
405 Views
Share
12 Jul 2024 08:50

Shanghai Henlius Biotech Update (2696.HK) - The Story Behind Privatization

Henlius has met the pre-condition for a potential Share Alternative Offer. Since HK$24.60 Offer Price (50% lower than HK$49.6/share IPO price) is...

Logo
664 Views
Share
bearishKelun Biotech
09 Jul 2024 09:48

Kelun-Biotech IPO Lock-Up Expiry - Strong Performance Leaves Pre-IPO Investors with Large Gains

Kelun Biotech (KB) raised around US$170m in its IPO in July 2023, the lockup on its pre-IPO shareholders is set to expire soon.

Logo
302 Views
Share
x